Calling all clinical researchers! Participate in Wellcome survey to share your biggest and boldest ideas
Wellcome is exploring how best to support public health and clinical interventions to improve global health. They are looking forward to what the next 10 years of global health trials might look like and want to hear your biggest and boldest ideas!
Wellcome want to know which health interventions you think have the potential to truly transform the health of people living in low- and middle-income countries (LMICs)? They are looking for large-scale evaluations of interventions that are in development but have not yet been formally evaluated (whether these are a product such as a diagnostic tool, drug, or vaccine, or a behavioural intervention, and whether they are targeted at individuals, communities or a combination of the two).
Wellcome are also interested in understanding how they can support more efficient evaluations that can provide definitive evidence and be much better linked with parallel policy work to allow faster uptake of evidence into practice.
Interventions should:
- be at late stage of development that evaluate efficacy or effectiveness (equivalent to pivotal Phase II or Phase III/IV)
- address the major causes of mortality and morbidity in LMICs
- have clear pathways to changing policy and guidelines
- address the issues of scalability and sustainability
- be evaluated at a large scale (either multi-country or multi-site)
To complete the survey visit: http://bit.ly/wellcome-global-health-survey
If you have any questions about the survey please contact Elena Netsi, Portfolio Manager Population Health at Wellcome, e.netsi@wellcome.ac.uk
Articles
Virtual Workshop: Recognition And Control Of Mtb Infected Cells: From Basics To The Clinic | 13 – 14June 2023
The Stop
TB Partnership Working Group on New TB Vaccines (WGNV) and the National
Institute for Allergy and Infectious Diseases (NIAID)are
co-hosting a workshop on the topic of Recognition and Control of Mtb
Infected Cells: From Basics to the Clinic. This workshop is intended to address
the need for correlates and to identify platforms that measure recognition or
control of the infected cell - especially in humans - as identified in the EDCTP/AIGHD Global Roadmap for
Research and Development of New TB Vaccines and the Strategic Framework for
New TB Vaccines in the Stop TB Partnership Global Plan to End TB 2023 - 2030.
The overall goals of this workshop
are to:
- elucidate the mechanisms by
which the immune system recognizes the Mtb-infected cell
- explore the degree to which
such recognition can lead to control of the intracellular microbe, and
- discuss the translational
implications of these observations
The workshop format will be largely
discussion-based. Each session will have three short presentations that will
provide a high-level overview of key topics within the session theme, followed
by a discussion between the session chairs, speakers, and participants.
Click here
to view the programme and
speakers.
This workshop is free of charge and
open to any participants interested in this topic.
Ssi/Isid Infectious Diseases Research Fellowships | Deadline For Applications: 16 June 2023
The International Society for Infectious Diseases (ISID) and the Swiss
Society for Infectious Diseases (SSI) are inviting applications for their joint
Infectious Diseases Research Fellowship Program. The purpose of this programme
is to support infectious disease physicians and scientists from under-resourced
countries through multidisciplinary clinical and laboratory training at a
select biomedical institution in Zurich, Switzerland. The one-year SSI/ISID
Fellowship programme is open to applicants who are 40 years or younger,
citizens and permanent residents of under-resourced countries or Eastern
Europe. The deadline for applications is 16 June 2023.
More information: https://na.eventscloud.com/eSites/748378/Homepage
Ethical Review Of Decentralized Clinical Trials (Dcts): Tools, Resources & Best Practices.
The MRCT Center and Medable convened a multi-stakeholder task force to address ethical and regulatory opportunities and challenges related to Decentralized Clinical Trials (DCTs). Join them on June 20, from 10 - 11 AM ET, for a joint webinar entitled, "Ethical Review of Decentralized Clinical Trials (DCTs): Tools, Resources & Best Practices."
During the webinar, Barbara Bierer (MRCT Center), Pam Tenaerts
(Medable) and Leanne Madre (Medable) will present a framework, recommendations,
and tools organized around 3 DCT domains: People, Remote Data Collection, and
Data Oversight. Best practices for the ethical review, approval, and conduct of
DCTs will be provided.
Clinical trial stakeholders (IRB/ECs,
HRPP, sites, sponsors, investigators, and others) to register for the webinar here